These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1902938)
1. Laryngeal involvement in scleromyxedema: a case report. Rapp MF; Guram M; Konrad HR; Mody N; Trapp R Otolaryngol Head Neck Surg; 1991 Mar; 104(3):362-5. PubMed ID: 1902938 [No Abstract] [Full Text] [Related]
2. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis. Jablonska S; Blaszczyk M Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735 [TBL] [Abstract][Full Text] [Related]
3. Images in clinical medicine. Scleromyxedema. Schanz S; Fierlbeck G N Engl J Med; 2004 Nov; 351(21):2218. PubMed ID: 15548782 [No Abstract] [Full Text] [Related]
4. Fatal scleromyxedema: report of a case and review of the literature. Godby A; Bergstresser PR; Chaker B; Pandya AG J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):289-94. PubMed ID: 9486700 [TBL] [Abstract][Full Text] [Related]
6. Treatment of scleromyxedema with 2-chlorodeoxyadenosine. Davis LS; Sanal S; Sangueza OP J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):288-90. PubMed ID: 8698907 [TBL] [Abstract][Full Text] [Related]
7. Scleromyxedema with dermato-neuro syndrome. Gonzalez J; Palangio M; Schwartz J; Klainer AS; Bisaccia E J Am Acad Dermatol; 2000 May; 42(5 Pt 2):927-8. PubMed ID: 10767707 [TBL] [Abstract][Full Text] [Related]
8. [Scleromyxedema with laryngeal changes. Beneficial results of the treatment with mucopolysaccharidases]. Cosgarea R; Cosgarea M; Turcu T Ann Dermatol Venereol; 1994; 121(2):159-61. PubMed ID: 7979029 [TBL] [Abstract][Full Text] [Related]
9. [Scleromyedema with special hyperkeratosis lesions and calcifications]. Ferrándiz C; Lecha M; Aguadé JP Med Cutan Ibero Lat Am; 1975; 3(5):353-9. PubMed ID: 1241787 [TBL] [Abstract][Full Text] [Related]
10. Scleromyxedema revisited. Pomann JJ; Rudner EJ Int J Dermatol; 2003 Jan; 42(1):31-5. PubMed ID: 12581140 [TBL] [Abstract][Full Text] [Related]
15. [Scleromyxedema Arndt-Gottron: a paraproteinemic disease]. Piper W; Hardmeier T; Schäfer E Schweiz Med Wochenschr; 1967 Jul; 97(26):829-38. PubMed ID: 5613452 [No Abstract] [Full Text] [Related]
16. The 'Doughnut Sign' revisited. Malakar S; Dhar S Dermatology; 1999; 199(4):373-4. PubMed ID: 10640858 [No Abstract] [Full Text] [Related]
17. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work. Lin YC; Wang HC; Shen JL J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228 [TBL] [Abstract][Full Text] [Related]